LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
LFCR on Nasdaq
Shares outstanding
37,253,000
Price per share
$7.56
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
16,391,449
Total reported value
$134,083,182
% of total 13F portfolios
0%
Share change
+303,868
Value change
+$2,563,826
Number of holders
70
Price from insider filings
$7.56
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Greenhaven Road Investment Management, L.P. 9.8% +25% $22,998,689 +$7,944,848 3,616,146 +53% Greenhaven Road Investment Management, L.P. 31 Dec 2024
22NW Fund, LP 7.5% -33% $20,768,278 -$9,716,865 2,975,398 -32% 22NW Fund, LP 27 May 2025
BlackRock, Inc. 5.1% +4% $15,541,966 +$536,503 1,899,903 +3.6% BlackRock, Inc. 31 Dec 2025
David Capital Partners, LLC 4.9% $11,467,080 1,803,000 David Capital Partners, LLC 31 Dec 2024

As of 31 Dec 2025, 70 institutional investors reported holding 16,391,449 shares of LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR). This represents 44% of the company’s total 37,253,000 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) together control 43% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
WYNNEFIELD CAPITAL INC 13% 4,703,216 0% 22% $38,472,306
Greenhaven Road Investment Management, L.P. 9.9% 3,682,573 -0.33% 13% $30,123,447
BlackRock, Inc. 5.1% 1,907,084 +3.6% 0% $15,599,947
VANGUARD GROUP INC 4.5% 1,673,666 +3.1% 0% $13,690,589
GEODE CAPITAL MANAGEMENT, LLC 2.1% 779,642 +0.78% 0% $6,379,153
MORGAN STANLEY 2% 751,505 +5.9% 0% $6,147,315
STATE STREET CORP 1.6% 585,386 +8.5% 0% $4,788,457
DCF Advisers, LLC 1.2% 442,000 -2.2% 1.2% $3,615,560
Quinn Opportunity Partners LLC 0.65% 242,670 +32% 0.09% $1,985,041
TOCQUEVILLE ASSET MANAGEMENT L.P. 0.41% 151,700 0% 0.02% $1,240,906
JANE STREET GROUP, LLC 0.32% 119,445 +80% 0% $977,060
Diametric Capital, LP 0.32% 117,591 +356% 0.26% $961,894
LPL Financial LLC 0.3% 112,790 -24% 0% $922,622
MARSHALL WACE, LLP 0.3% 110,621 -3% 0% $904,882
Squarepoint Ops LLC 0.3% 110,499 -27% 0% $903,882
GOLDMAN SACHS GROUP INC 0.25% 93,651 +69% 0% $766,065
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.24% 87,713 +0.03% 0% $717,492
GAMCO INVESTORS, INC. ET AL 0.22% 83,800 -0.83% 0.01% $685,484
GSA CAPITAL PARTNERS LLP 0.22% 82,794 0.06% $677,000
Pale Fire Capital SE 0.19% 71,040 +9.9% 0.07% $581,107
Bank of New York Mellon Corp 0.16% 58,888 -31% 0% $481,704
UBS Group AG 0.15% 54,761 -41% 0% $447,945
BARCLAYS PLC 0.13% 46,696 +15% 0% $381,973
Nuveen, LLC 0.1% 35,850 0% 0% $293,253
Steward Partners Investment Advisory, LLC 0.09% 34,215 +0.96% 0% $279,879

Institutional Holders of LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 16,391,449 $134,083,182 +$2,563,826 $8.18 70
2025 Q3 24,334,794 $179,104,808 -$442,653 $7.36 98
2025 Q2 24,384,958 $198,008,217 +$13,339,387 $8.12 84
2025 Q1 22,755,067 $160,201,265 -$2,326,304 $7.04 85
2024 Q4 23,042,098 $171,205,266 +$31,378,307 $7.43 74
2024 Q3 18,933,619 $93,344,132 +$959,877 $4.93 80
2024 Q2 18,597,383 $95,407,619 -$6,051,109 $5.13 73
2024 Q1 21,527,122 $114,309,004 +$1,281,084 $5.31 75
2023 Q4 21,214,493 $131,315,483 +$7,746,225 $6.19 77
2023 Q3 17,649,982 $132,309,917 -$4,239,641 $7.54 67
2023 Q2 17,960,139 $173,672,855 -$23,585,436 $9.67 73
2023 Q1 21,626,729 $81,665,566 -$19,155,973 $3.78 79
2022 Q4 24,699,229 $160,060,929 -$420,882 $6.48 92
2022 Q3 24,756,452 $220,096,095 -$5,076,219 $8.89 84
2022 Q2 25,281,897 $252,055,903 -$4,813,620 $9.97 86
2022 Q1 23,496,502 $272,006,071 -$4,453,715 $11.58 94
2021 Q4 25,875,011 $287,157,179 +$3,096,368 $11.10 95
2021 Q3 25,537,059 $235,449,630 +$11,336,792 $9.22 91
2021 Q2 25,595,693 $287,942,521 -$5,835,307 $11.25 95
2021 Q1 25,969,624 $275,201,016 -$6,203,031 $10.60 92
2020 Q4 26,546,714 $288,027,507 -$1,865,390 $10.85 95
2020 Q3 27,293,895 $265,303,644 +$8,398,552 $9.72 95
2020 Q2 26,759,176 $213,024,082 -$2,393,394 $7.96 91
2020 Q1 27,069,384 $235,223,542 -$2,453,651 $8.69 87
2019 Q4 27,094,595 $306,434,334 +$278,864 $11.31 92
2019 Q3 26,498,684 $287,625,125 -$10,583,915 $10.87 102
2019 Q2 27,497,586 $257,653,097 +$10,011,387 $9.37 98
2019 Q1 26,312,887 $323,120,159 +$5,328,462 $12.28 90
2018 Q4 25,883,944 $306,456,062 -$563,058 $11.84 88
2018 Q3 25,680,348 $367,065,569 -$2,817,222 $14.40 89
2018 Q2 25,073,308 $373,595,030 -$6,657,193 $14.90 89
2018 Q1 26,316,857 $343,465,751 +$5,904,468 $13.05 88
2017 Q4 25,838,571 $325,371,521 -$304,837 $12.60 90
2017 Q3 25,804,476 $334,160,959 +$6,036,656 $12.95 92
2017 Q2 25,319,960 $375,969,466 +$3,371,779 $14.85 92
2017 Q1 25,099,442 $301,208,568 +$26,792,518 $12.00 83
2016 Q4 24,664,192 $340,389,514 -$4,315,145 $13.80 91
2016 Q3 25,035,867 $335,724,442 -$8,276,505 $13.41 90
2016 Q2 25,716,341 $276,698,218 +$13,954,300 $10.76 92
2016 Q1 25,062,413 $263,156,774 +$7,503,955 $10.50 91
2015 Q4 24,362,954 $288,513,037 +$6,283,639 $11.83 106
2015 Q3 23,756,250 $277,238,057 -$6,250,112 $11.67 108
2015 Q2 24,236,757 $349,729,789 -$429,367 $14.43 107
2015 Q1 24,035,177 $335,230,454 -$392,081 $13.95 97
2014 Q4 24,080,381 $332,562,030 -$1,269,800 $13.81 105
2014 Q3 24,257,148 $294,986,600 +$2,810,099 $12.25 105
2014 Q2 23,981,587 $299,475,311 +$4,217,262 $12.49 99
2014 Q1 23,665,087 $264,250,906 -$9,506,174 $11.16 96